A single (assessor) - blind, randomised, three-period, cross-over study to compare the safety of flutiform pMDI, fluticasone pMDI and beclometasone Autohaler in paediatric subjects aged 5 to less than 12 years with mild persistent asthma by means of knemometry.

Trial Profile

A single (assessor) - blind, randomised, three-period, cross-over study to compare the safety of flutiform pMDI, fluticasone pMDI and beclometasone Autohaler in paediatric subjects aged 5 to less than 12 years with mild persistent asthma by means of knemometry.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Sep 2015

At a glance

  • Drugs Formoterol/fluticasone propionate (Primary) ; Beclometasone; Fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Mundipharma International
  • Most Recent Events

    • 27 Jan 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 06 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 10 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top